ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.3819T>G (p.Asn1273Lys)

gnomAD frequency: 0.00001  dbSNP: rs759642651
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000538478 SCV000624926 benign Hereditary nonpolyposis colorectal neoplasms 2023-10-05 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000774615 SCV000908435 uncertain significance Hereditary cancer-predisposing syndrome 2022-09-12 criteria provided, single submitter clinical testing This missense variant replaces asparagine with lysine at codon 1273 of the MSH6 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 2/251052 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Ambry Genetics RCV000774615 SCV001182811 uncertain significance Hereditary cancer-predisposing syndrome 2022-06-07 criteria provided, single submitter clinical testing The p.N1273K variant (also known as c.3819T>G), located in coding exon 9 of the MSH6 gene, results from a T to G substitution at nucleotide position 3819. The asparagine at codon 1273 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GeneDx RCV002264952 SCV002546614 uncertain significance not provided 2022-07-07 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with premature ovarian insufficiency and unspecified cancer history (Tang et al., 2020); This variant is associated with the following publications: (PMID: 17531815, 21120944, 32789750)
Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University RCV003153677 SCV003843670 likely pathogenic Ovarian cancer 2022-01-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.